Cutaneous pseudolymphomas: inflammatory reactive proliferations
- PMID: 24191857
- DOI: 10.1586/17474086.2013.845000
Cutaneous pseudolymphomas: inflammatory reactive proliferations
Abstract
Skin is an organ of the immune and lymphoid systems. Lymphoid tissue analogous to gut mucosa-associated lymphoid tissue proliferates in the skin in response to antigenic stimulation. This putative skin-associated tissue is called skin-associated lymphoid tissues (SALT). In the opinion of this author, cutaneous pseudolymphomas represent inflammatory, reactive proliferations of SALT following antigenic stimulation of the cutaneous immune cells. Cutaneous pseudolymphomas commonly involve the exposed areas such as head and neck region and upper extremities. They appear as localized nodules, plaques or noduloplaques. They include B- and T-cell pseudolymphomas. Their histologic patterns include nodular, diffuse, band-like and folliculitis-like morphology. Most pseudolymphomas are idiopathic, but some are secondary to known etiologies (drug intake, arthropod assaults, infectious agents and traumas). Cutaneous pseudolymphomas are usually polyclonal proliferations that regress spontaneously or after treating the underlying etiology. Rare cases harbor clonal lymphoid populations and can progress to low-grade lymphomas. Herein, the author reviews the etiology, clinicopathologic features and diagnosis of the cutaneous pseudolymphomas.
Similar articles
-
Cutaneous Pseudolymphomas.Actas Dermosifiliogr. 2016 Oct;107(8):640-51. doi: 10.1016/j.ad.2016.05.003. Epub 2016 Jun 8. Actas Dermosifiliogr. 2016. PMID: 27289134 Review. English, Spanish.
-
Cutaneous pseudolymphomas.J Am Acad Dermatol. 1998 Jun;38(6 Pt 1):877-95; quiz 896-7. doi: 10.1016/s0190-9622(98)70154-9. J Am Acad Dermatol. 1998. PMID: 9631994 Review.
-
Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.Keio J Med. 2001 Dec;50(4):269-73. doi: 10.2302/kjm.50.269. Keio J Med. 2001. PMID: 11806505
-
A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.Dermatol Ther. 2022 Nov;35(11):e15812. doi: 10.1111/dth.15812. Epub 2022 Sep 24. Dermatol Ther. 2022. PMID: 36088631
-
IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma.Am J Surg Pathol. 2009 Nov;33(11):1713-9. doi: 10.1097/PAS.0b013e3181b201de. Am J Surg Pathol. 2009. PMID: 19701072
Cited by
-
The Puzzle of Papules Over Face and Extrafacial Areas: A Rare Case of Disseminated Idiopathic T-Cell Pseudolymphoma.Indian Dermatol Online J. 2021 Mar 2;12(2):312-315. doi: 10.4103/idoj.IDOJ_568_20. eCollection 2021 Mar-Apr. Indian Dermatol Online J. 2021. PMID: 33959532 Free PMC article.
-
Cutaneous pseudolymphoma: A clinicopathological study and immunohistochemical patterns.Caspian J Intern Med. 2021 Apr;12(3):283-289. doi: 10.22088/cjim.12.3.283. Caspian J Intern Med. 2021. PMID: 34221277 Free PMC article.
-
Borrelial pseudolymphoma of the nose.BMJ Case Rep. 2015 Jan 7;2015:bcr2014205688. doi: 10.1136/bcr-2014-205688. BMJ Case Rep. 2015. PMID: 25568264 Free PMC article.
-
Tattoos: risks and complications, clinical and histopathological approach.An Bras Dermatol. 2024 Jul-Aug;99(4):491-502. doi: 10.1016/j.abd.2023.07.004. Epub 2024 Mar 22. An Bras Dermatol. 2024. PMID: 38521707 Free PMC article. Review.
-
[31/f with livid erythematous papules and nodules : Preparation for the specialist examination: part 6].Hautarzt. 2018 Nov;69(Suppl 2):100-104. doi: 10.1007/s00105-018-4240-4. Hautarzt. 2018. PMID: 30374538 German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical